AI Assistant
Blog
Pricing
Log In
Sign Up
Pluripotent cell–specific inhibitors (PluriSIns) to reduce the tumorigenic risk of stem cell–based therapies
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
